Replies to post #362315 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Not the first time he has confused revenue with profitability. This would only be true if all the expenses (COGS, R&D, G&A, etc) could be swallowed perfectly by the acquirer. G&A & R&D could happen with maybe some savings on the COGS side as well, but no company assumes a zero cost structure during an M&A transaction.

This was not the only ridiculous comment made, but will leave it at that for now.

The doctorate seems to ignore basic financial and economic principles in LaLa land.

[no2koolaid]

kayak wench,

Thanks for the comments. I did not mean "Break Even" in the financial sense. If I did t would have posted some financial analysis as I did on this occasion...https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164387519

Perhaps, I should have caught my language in an edit but did not. Still, I find it interesting that an effort to provide a hypothetical example - one that would not happen - gets evaluated for the wording on the example rather than the point of the post - Elite' p/s does not reflect its value and it is manipulated.

Any comments on the manipulation link? Anyone? Anyone? Bueller?